Results 151 to 160 of about 20,000 (189)

Overcoming amplification-mediated resistance to sotorasib by dose re-escalation in KRAS G12C mutant NSCLC: a case report. [PDF]

Oncologist
Vitale A, Vita E, Stefani A, Cancellieri A, Lococo F, Tortora G, Bria E.   +6 more
europepmc   +1 more source

Investigation of Natural Resistance to Fostemsavir and Lenacapavir in Naïve Primary Infections by Ultra-Deep Sequencing of near Full-Length HIV-1 Genomes. [PDF]

Viruses
Lazzari E, Rozera G, Gagliardini R, Mazzotta V, Fabeni L, Forbici F, Berno G, Cosentino C, Girardi E, Antinori A, Maggi F, Abbate I.   +11 more
europepmc   +1 more source

Stereoisomers of Chiral Methyl-Substituted Symmetric and Asymmetric Aryl Piperazinium Compounds Exhibit Distinct Selectivity for α9 and α7 Nicotinic Acetylcholine Receptors. [PDF]

ACS Chem Neurosci
Andleeb H, Papke RL, Richter K, Grau V, Hone AJ, Kerr A, McIntosh JM, Stokes C, Thakur GA.   +8 more
europepmc   +1 more source

Predictors of treatment-emergent resistance to dolutegravir. [PDF]

Lancet HIV
McCluskey SM, Gandhi M.
europepmc   +1 more source

Baseline neutrophil-lymphocyte ratio (NLR) predicts toxicity and survival in HR+/HER-2 breast cancer patients treated with CDK4/6 inhibitors. [PDF]

Breast
Badran O, Darawshe A, Sharif S, Yosef S, Bar-Sela G.   +4 more
europepmc   +1 more source

PHEOCHROMOCYTOMA CRISIS TREATED WITH URAPIDIL: A CASE REPORT. [PDF]

Acta Clin Croat
Bakula M, Tomašić L, Kokan I, Mucić K, Marić N, Bakula M.   +5 more
europepmc   +1 more source

Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with <i>MTAP</i> Deletion. [PDF]

J Med Chem
Cottrell KM, Briggs KJ, Tsai A, Tonini MR, Whittington DA, Gong S, Liang C, McCarren P, Zhang M, Zhang W, Huang A, Maxwell JP.   +11 more
europepmc   +1 more source

Population pharmacokinetics of bictegravir in real-world people with HIV. [PDF]

J Antimicrob Chemother
Ekobena P, Briki M, Dao K, Marzolini C, Andre P, Buclin T, Cavassini M, Guidi M, Thoueille P, Swiss HIV Cohort Study .   +9 more
europepmc   +1 more source

Phase I study of palbociclib with cisplatin or carboplatin in the management of patients with advanced pancreatic cancer. [PDF]

Oncologist
Alese OB, Harvey RD, Wu C, Hitron E, Collins H, Scott S, Steuer C, Bilen MA, Carthon BC, Switchenko JM, Ramalingam SS, Owonikoko TK.   +11 more
europepmc   +1 more source